SKP2 and hepatocellular carcinoma: A recent research indicated that SKP-2, an oncogenic subunit of an ubiquitin ligase complex, which founctions as a critical regulator of S phase progression, could promote degradation of RASSF1A at the G1/S checkpoint and then lead to the cell cycle proceeding in hepatocellular carcinoma[29].